PEDF as an Emerging Therapeutic Candidate for Osteosarcoma

E-ISSN： 1873-5576|8|8|683-690

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.8, Iss.8, 2008-12, pp. : 683-690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for high-grade osteosarcoma

By Hattinger Claudia Maria Pasello Michela Ferrari Stefano Picci Piero Serra Massimo

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. : 615-634

Informa Healthcare

Access to resources Recommend Favorite

Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease

By Rychli Kathrin Huber Kurt Wojta Johann

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 11, 2009-11 ,pp. : 1295-1302

Informa Healthcare

Access to resources Recommend Favorite

Candidate Genes for Osteoporosis: Therapeutic Implications

By Niu T.

American Journal of PharmacoGenomics, Vol. 1, Iss. 1, 2001-01 ,pp. : 11-19

Adis International

Access to resources Recommend Favorite

Emerging therapeutic targets in angiogenesis

By Jones A. Zhang H-T. Harris A.L.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 213-229

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapeutic agents for onychomycosis

By E Piérard Gérald E Arrese Jorge Quatresooz Pascale PiÉrard-Franchimont C

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 3, 2007-09 ,pp. : 345-353

Informa Healthcare

Access to resources Recommend Favorite